8COI
Human adenovirus-derived synthetic ADDobody binder
8COI の概要
| エントリーDOI | 10.2210/pdb8coi/pdb |
| 分子名称 | ADDobody (1 entity in total) |
| 機能のキーワード | penton base, crown domain, human adenovirus, viral protein |
| 由来する生物種 | Human adenovirus sp. |
| タンパク質・核酸の鎖数 | 20 |
| 化学式量合計 | 704970.24 |
| 構造登録者 | Buzas, D.,Toelzer, C.,Gupta, K.,Berger-Schaffitzel, C.,Berger, I. (登録日: 2023-02-28, 公開日: 2023-12-27, 最終更新日: 2024-03-20) |
| 主引用文献 | Buzas, D.,Sun, H.,Toelzer, C.,Yadav, S.K.N.,Borucu, U.,Gautam, G.,Gupta, K.,Bufton, J.C.,Capin, J.,Sessions, R.B.,Garzoni, F.,Berger, I.,Schaffitzel, C. Engineering the ADDobody protein scaffold for generation of high-avidity ADDomer super-binders. Structure, 32:342-, 2024 Cited by PubMed Abstract: Adenovirus-derived nanoparticles (ADDomer) comprise 60 copies of adenovirus penton base protein (PBP). ADDomer is thermostable, rendering the storage, transport, and deployment of ADDomer-based therapeutics independent of a cold chain. To expand the scope of ADDomers for new applications, we engineered ADDobodies, representing PBP crown domain, genetically separated from PBP multimerization domain. We inserted heterologous sequences into hyper-variable loops, resulting in monomeric, thermostable ADDobodies expressed at high yields in Escherichia coli. The X-ray structure of an ADDobody prototype validated our design. ADDobodies can be used in ribosome display experiments to select a specific binder against a target, with an enrichment factor of ∼10-fold per round. ADDobodies can be re-converted into ADDomers by genetically reconnecting the selected ADDobody with the PBP multimerization domain from a different species, giving rise to a multivalent nanoparticle, called Chimera, confirmed by a 2.2 Å electron cryo-microscopy structure. Chimera comprises 60 binding sites, resulting in ultra-high, picomolar avidity to the target. PubMed: 38198950DOI: 10.1016/j.str.2023.12.010 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (3.17 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






